These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1658749)

  • 1. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.
    Chen U; Scheuermann RH; Wirth T; Gerster T; Roeder RG; Harshman K; Berger C
    Nucleic Acids Res; 1991 Nov; 19(21):5981-9. PubMed ID: 1658749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution.
    Marcuzzi A; Van Ness B; Rouse T; Lafrenz D
    Nucleic Acids Res; 1989 Dec; 17(24):10455-72. PubMed ID: 2481271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.
    Chen-Bettecken U; Wecker E; Schimpl A
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7384-8. PubMed ID: 3933005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT; Naides SJ; Benacerraf B; Sy MS
    J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
    Schliephake DE; Schimpl A
    Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.
    Libermann TA; Lenardo M; Baltimore D
    Mol Cell Biol; 1990 Jun; 10(6):3155-62. PubMed ID: 2111447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B-cell differentiation: anti-mu antibodies have opposite effects on differentiation stimulated by bacterial lipopolysaccharide and 8-mercaptoguanosine.
    Rollins-Smith LA; Lawton AR
    J Mol Cell Immunol; 1988; 4(1):9-19. PubMed ID: 3266925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridomas derived from lipopolysaccharide-activated anti-mu-treated B cells have active suppression of IgM secretion, demonstrable by secondary fusion.
    Lawton AR; Summerlin VS; Dooley JS
    J Immunol; 1990 Nov; 145(10):3177-80. PubMed ID: 2230114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu.
    Kuruganti U; Henderson LA; Garner RE; Asofsky R; Baker PJ; Domer JE
    J Leukoc Biol; 1988 Nov; 44(5):422-33. PubMed ID: 3141542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional analysis of inhibition of lipopolysaccharide response by anti-IgM.
    Moore BB; Ariizumi K; Tucker PW; Yuan D
    J Immunol; 1993 Apr; 150(8 Pt 1):3366-74. PubMed ID: 8468476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate transcriptional control of murine endogenous retrovirus and Ig genes during B cell differentiation.
    Hummell DS; Dooley JS; Khan AS; Lawton AR
    J Immunol; 1993 Sep; 151(6):3131-9. PubMed ID: 8397253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the reactivity of four anti-mouse IgM allotype antibodies with mu+ B lineage cells at various stages of differentiation.
    Velardi A; Kubagawa H; Kearney JF
    J Immunol; 1984 Oct; 133(4):2098-103. PubMed ID: 6432906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mu antibody blocks LPS driven B cell differentiation by suppressing specific mRNAs.
    Flahart RE; Lawton AR
    J Mol Cell Immunol; 1987; 3(2):61-8. PubMed ID: 3151063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site.
    Phillips C; Schimpl A; Dietrich-Goetz W; Clements JB; Virtanen A
    Eur J Immunol; 1996 Dec; 26(12):3144-52. PubMed ID: 8977316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
    Nossal GJ; Pike BL; Battye FL
    Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3' enhancer.
    Arulampalam V; Grant PA; Samuelsson A; Lendahl U; Pettersson S
    Eur J Immunol; 1994 Jul; 24(7):1671-7. PubMed ID: 7517878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
    Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
    Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cell proliferation and mu-RNA processing during activation of mouse B-cells by anti-mu and T lymphokines.
    Chen U
    Mol Immunol; 1990 Dec; 27(12):1249-57. PubMed ID: 2125697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.